Organism ID:   | NPO41862 |
Organism Name:   | A new engineered strain of Escherichia coli BL21(DE3) [SS, SE, CPR, McSE, AtCPR,] |
Native / Engineered Organism:   | Engineered Organism |
Matched Taxonomy Level:   | Strain |
Organism External ID:   | NCBI_Taxonomy_ID[ n.a.] |
Organism Synonyms:   | |
Genus:   | Escherichia |
Family:   | Enterobacteriaceae |
Kingdom:   | n.a. |
SuperKingdom:   | Bacteria |
Natural Product ID | Prefer Name (or InChiKey) | IUPAC Name | Number of Targets | Number of Activity Records |
---|---|---|---|---|
NPC490496 | taxa-4(5),11(12)-diene | n.a. | 0 | 0 |
Organism Name | Producer Organism | Inducer Organism | NP ID | NP Name | Effect of Co-culture | Reference |
---|
Organism Name | Parent Organism Name | Engineered Gene in Organism | Purpose of Engineering | Engineering Category | Engineering Description | NP ID | NP Name | NP Yeild of Parent Organism | NP Yeild of Engineered Organism | Yeild Change | Reference |
---|---|---|---|---|---|---|---|---|---|---|---|
A new engineered strain of Escherichia coli BL21(DE3) | Escherichia coli BL21(DE3) | SS, SE, CPR, McSE, AtCPR, | Increase NP yield | n.a. | dammarenediol-II biosynthetic pathway was reconstituted in E. coli by co-expression of squalene synthase (SS), squalene epoxidase (SE), NADPH-cytochrome P450 reductase (CPR) from Saccharomyces cerevisiae, and SE from Methylococcus capsulatus (McSE), NADPH-cytochrome P450 reductase (CPR) from Arabidopsis thaliana. | NPC490496 | taxadiene | n.a. | 8.63 mg/L | n.a. |
PMID[26739962] |
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|